Neuronetics is trading 5.37% up in pre-market at $3.14, rising from the August 25 close of $2.98; no clear catalyst has been identified.

  • No company-specific announcement, filing, analyst action, or overnight catalyst explaining the August 26 move was identified.
  • Latest investor-relations updates remain the August 11 second-quarter results and August 3 announcement; broader markets are nearly flat.
  • Limited pre-market liquidity or a delayed reaction to prior news may be factors, but causation is unconfirmed.